PADCEV Patient Assistance Program

The PADCEV Patient Assistance Programa (PAP) provides PADCEVTM (enfortumab vedotin-ejfv) at no cost to uninsured patients who meet the program eligibility requirements.

Eligibility Requirements

PADCEV Support SolutionsSM can evaluate whether you are eligible for the PAP program. For more information, contact us at 1‑888‑402‑0627. We are available Monday–Friday, 8:30 am–8:00 pm ET.

You may be eligible for the PADCEV Patient Assistance Program if you:

  • Do not have insurance or have insurance that excludes coverage for PADCEV,
  • Have a verifiable shipping address within the United States,
  • Have been prescribed PADCEV for an FDA-approved indication, AND
  • Meet the program financial eligibility requirements

Application Process

Your healthcare provider can start the application process by submitting the PAP application, which includes the necessary information so that PADCEV Support Solutions can assess your eligibility for the PAP program.

Once you are approved for the PADCEV Patient Assistance Program, we will notify both you and your healthcare provider that you have been enrolled. Your PAP medicine will then be shipped directly to your healthcare provider.

PADCEV Support Solutions is a component of Astellas Pharma Support SolutionsSM.

a Subject to eligibility. Void where prohibited by law.

PADCEVTM is a trademark jointly owned by Agensys, Inc. and Seattle Genetics, Inc.